“Revenues in this sector will grow due to the high potential of the healthcare services market. Romania spends just EUR9.5 per capita a year on medical testing services, while countries in Western Europe spend an average EUR20.4 per capita, as the system is more focused on prevention. The private healthcare sector is more advanced in terms of medical tests and imaging but our expansion plans target the public sector as well, which requires massive investments,” said Vasileios Chrelias, general manager of Diamedix.
The diagnostic solutions market has expanded constantly in recent years, in direct ratio to growth in demand for medical services. The local private healthcare services market reached a record EUR2.3 billion in 2018. Romania has one of the highest growth rates for In Vitro diagnostic products (IVD reagents and equipment), of 12%, compared with a European Union average of 1.3%.
Diamedix was founded in 1996 by Chrelias. In 2009, GED Capital bought 80% of the company. The fund also invested in Continental Hotels, Infopress and Happy Tour in Romania.